Form 4 Tracker
CRISPR Therapeutics AG
CRSP

29 insider filings · Latest: Jun 5, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 29, 2026Jun 1 9:35 PMNaimish PatelChief Medical Officer
Sale
3,786$55.62$210.6K19,357(D)

View →

Mar 23, 2026Mar 24 9:38 PMJames R. KasingerGeneral Counsel and Secretary
Sale
3,182$46.78$148.9K94,308(D)

View →

Mar 23, 2026Mar 24 9:37 PMSamarth KulkarniDirector, Chief Executive Officer
Sale
10,020$46.78$468.7K255,501(D)

View →

Mar 23, 2026Mar 24 9:37 PMRaju PrasadChief Financial Officer
Sale
3,708$46.78$173.5K15,565(D)

View →

Mar 16, 2026Mar 17 9:37 PMNaimish PatelChief Medical Officer
Sale
3,150$48.26$152.0K13,143(D)

View →

Mar 16, 2026Mar 17 9:37 PMRaju PrasadChief Financial Officer
Sale
9,869$48.26$476.3K13,773(D)

View →

Mar 16, 2026Mar 17 9:35 PMJames R. KasingerGeneral Counsel and Secretary
Sale
3,450$48.26$166.5K91,240(D)

View →

Mar 16, 2026Mar 17 9:35 PMSamarth KulkarniDirector, Chief Executive Officer
Sale
10,349$48.26$499.4K245,834(D)

View →

Mar 11, 2026Mar 12 9:35 PMJames R. KasingerGeneral Counsel and Secretary
Sale
2,800$52.80$147.8K87,815(D)

View →

Mar 11, 2026Mar 12 9:35 PMSamarth KulkarniDirector, Chief Executive Officer
Sale
9,798$52.80$517.3K235,558(D)

View →

Feb 19, 2026Feb 20 10:36 PMSamarth KulkarniDirector, Chief Executive Officer
Sale
6,967$52.58$366.3K226,106(D)

View →

Feb 19, 2026Feb 20 10:35 PMJames R. KasingerGeneral Counsel and Secretary
Sale
2,112$52.58$111.0K85,115(D)

View →

Apr 3, 2025Jan 27 10:35 PMNaimish PatelChief Medical Officer
Purchase
1,508$32.96$49.7K1,508(D)

View →

Jan 22, 2026Jan 26 10:35 PMRaju PrasadChief Financial Officer
Sale
34,972$60.19$2.1M6,767(D)

View →

Jan 22, 2026Jan 22 10:55 PMSamarth KulkarniDirector, Chief Executive Officer
Sale
60,000$60.23$3.6M134,201(D)

View →

Jan 20, 2026Jan 22 10:55 PMSamarth KulkarniDirector, Chief Executive Officer
Sale
30,000$51.75$1.6M194,201(D)

View →

Jan 22, 2026Jan 22 10:15 PMSamarth Kulkarni
Proposed Sale
60,000$60.81$3.6M

View →

Jan 22, 2026Jan 22 9:03 PMRAJU PRASAD
Proposed Sale
34,972$60.19$2.1M

View →

Jan 20, 2026Jan 20 10:11 PMSamarth Kulkarni
Proposed Sale
30,000$52.61$1.6M

View →

Jan 6, 2026Jan 6 10:11 PMRAJU PRASAD
Proposed Sale
29,700$60.16$1.8M

View →

Page 1 of 2

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 20, 2026Mar 24 9:36 PMNaimish PatelChief Medical Officer
Grant/Award
68,499$46.2430,000(D)

View →

Mar 14, 2026Mar 17 9:37 PMNaimish PatelChief Medical Officer
Option Exercise
8,12524,375(D)

View →

Mar 14, 2026Mar 17 9:37 PMRaju PrasadChief Financial Officer
Option Exercise
16,87520,625(D)

View →

Mar 14, 2026Mar 17 9:35 PMJames R. KasingerGeneral Counsel and Secretary
Option Exercise
6,87520,625(D)

View →

Mar 14, 2026Mar 17 9:35 PMSamarth KulkarniDirector, Chief Executive Officer
Option Exercise
20,62561,875(D)

View →

Mar 10, 2026Mar 12 9:35 PMJames R. KasingerGeneral Counsel and Secretary
Option Exercise
5,5005,500(D)

View →

Mar 10, 2026Mar 12 9:35 PMSamarth KulkarniDirector, Chief Executive Officer
Option Exercise
19,25019,250(D)

View →

Feb 18, 2026Feb 20 10:36 PMSamarth KulkarniDirector, Chief Executive Officer
Option Exercise
13,2500(D)

View →

Feb 18, 2026Feb 20 10:35 PMJames R. KasingerGeneral Counsel and Secretary
Option Exercise
3,8250(D)

View →

Jan 22, 2026Jan 26 10:35 PMRaju PrasadChief Financial Officer
Option Exercise
34,972$45.1541,667(D)

View →

← Previous

Page 2 of 2